Dow Swings to Loss as Sales Decline Across All Segments
The chemical maker swung to a loss of $835 million, or $1.18 a share, for the quarter, compared with net income of $439 million, or 62 cents a share, in the prior-year period.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
VeriSign (VRSN) Announced Increased Earnings
In July 2025, VeriSign expanded its buyback authorization and announced increased earnings, alongside a declared cash dividend. Despite these positive developments, the company's share price declined by 5.90% over the past month. This decline coincided with a broader market downturn, driven by global tariff uncertainties and disappointing job data. While VeriSign's solid financial results might have typically buoyed investor confidence, the market context placed downward pressure on its stock. The company's follow-on equity offering also added complexity to its share dynamics over this period, contributing to a challenging market performance. Every company has risks, and we've spotted 3 warning signs for VeriSign (of which 1 shouldn't be ignored!) you should know about. Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge. VeriSign's recent expansion of its buyback authorization and earnings increase, juxtaposed with a share price decline of 5.90% during July, showcases the complexity of market dynamics. This decline coincided with external market pressures like global tariff uncertainties and disappointing job data. Despite these pressures, VeriSign's solid financial results and strategic initiatives may support long-term growth. Notably, in the last year, VeriSign's total return, including dividends, was 41.76%, highlighting its strong performance over a broader timeline despite recent challenges. Comparatively, over the past year, VeriSign outperformed the US market, which returned 16.8%, and also exceeded the US IT industry with its 24.5% return. The company's ongoing initiatives, such as improving domain registration trends and marketing strategies, could positively impact revenue growth, while the introduction of dividends reflects financial stability that could enhance earnings forecasts. VeriSign's current share price of US$265.37 is below the analyst consensus price target of US$309.0, indicating a 16.44% discount, which resonates with the potential for value growth should the company's revenue and earnings forecasts materialize as expected. In light of our recent valuation report, it seems possible that VeriSign is trading beyond its estimated value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include VRSN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
15 minutes ago
- Yahoo
CRISPR Therapeutics (CRSP) Sees 47% Price Increase Over Last Quarter
CRISPR Therapeutics recently announced significant developments in its in vivo cardiovascular disease programs, notably CTX310 and CTX320, which may have contributed to the company's 47% share price increase over the last quarter. The company's inclusion in multiple indices further enhances its market presence, potentially impacting investor interest positively. Meanwhile, CRISPR reported a net loss in its Q1 earnings, although revenue increased year-over-year. Despite a volatile market backdrop, characterized by declining major indices due to weak job reports and tariff concerns, CRISPR's advancements in therapeutic programs and strategic index additions contrasted against broader market movements. We've spotted 1 risk for CRISPR Therapeutics you should be aware of. Uncover the next big thing with financially sound penny stocks that balance risk and reward. Over the past year, CRISPR Therapeutics reported a total shareholder return of 9.74%. While the company's shares outperformed the US Biotechs industry, which returned a decline of 8.4% over the same period, it lagged behind the broader US Market's 17.7% return. The favorable performance relative to its industry can be linked to its strategic advancements in cardiovascular disease programs and inclusion in various Russell indices. The recent developments highlighted in the introduction, particularly the positive updates in CRISPR's cardiovascular programs and index additions, could potentially influence expectations around future revenue and earnings. Analysts forecast strong revenue growth of 57.3% annually, despite the company's forecast to remain unprofitable over the next three years. Meanwhile, with the current share price at $56.09, the market seems to discount the consensus analyst price target of $80.91, reflecting a substantial perceived upside potential in the stock. This price movement suggests that investors might see potential growth opportunities, even as the company navigates its profitability challenges. The valuation report we've compiled suggests that CRISPR Therapeutics' current price could be quite moderate. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CRSP. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
15 minutes ago
- Yahoo
An Amazon seller doing 7 figures says one strategic addition has doubled her profit
Lisa Harrington started selling clothes on eBay before transitioning to Amazon. Her business selling interior cat doors took off after hiring a PPC coach. She emphasizes investing in coaching and networking for long-term business growth. Lisa Harrington's e-commerce career began in the early 2010s when she started selling clothing, purses, and other items in her closet that she didn't need anymore. She used the eBay profit to launch her first Amazon product — dog harnesses — and sold enough to quit her corporate job in 2016. She eventually created and patented interior cat doors, which have become a top-selling Amazon product and bring in seven figures in annual revenue. Harrington, who's been doing e-commerce for more than a decade, can pinpoint one decision that took her business to the next level: hiring a PPC coach. PPC (pay-per-click) refers to Amazon's advertising platform, where sellers can pay to have their products displayed prominently. Many sellers consider ads an essential aspect of succeeding in the competitive e-commerce space. For years, "I had a very low spend on my advertisement," Harrington told Business Insider. Figuring out how to run Amazon ads wasn't how she wanted to spend her time. "I just didn't have much interest in it. I really wanted to focus on branding and product development, but it has such an enormous impact on your profit and loss statement that you really can't ignore it." The idea to hire a coach came from an industry event. "I remember talking to this woman, and she's like, 'I hire a coach for everything I don't know how to do. It is the fastest way to level up,'" recalled Harrington. She took the advice, found a coach to help her specifically with ads, and, "in the time I've worked with her, my profit has doubled," said Harrington. It took her six months to find the right fit. "Coaches are hard to find. But when you do find one, it levels your business up," she said. Over the last couple of years, her PPC coach has become more of a general business coach. They discuss everything from product development to effective employee management. "She's the only person I can talk to about every aspect of my business. She not only has the expertise but has the background information, so I can spitball with her, solve problems, and come up with great ideas," said Harrington. The full-time entrepreneur and mother of two kids doesn't hesitate to outsource when she can. "I try to get a coach for everything because, thankfully, I've gotten to the point where I can pay people to help me," she said. "That, in some cases, tends to be a cheaper way to learn a skill or a cheaper way to get something done." Harrington is also a member of the elite group of seven-figure Amazon sellers called Million Dollar Sellers. Members must complete an interview and application and pay $7,497 a year to join the group, which grants them access to exclusive events and a robust network of top-tier entrepreneurs. She's adamant that investing in yourself "always pays dividends," she said. "The knowledge that you gain, the networks that you gain, the experience shares that you hear, the tips and tricks that you get access to — not only is that short-term helping your business and helping your profit and loss statement, but you're also learning all of those things, so that if everything fell apart tomorrow, you could rebuild it again." Read the original article on Business Insider Sign in to access your portfolio
